Table1_Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical Pseudomonas aeruginosa isolates from Switzerland.docx

Table1_Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical Pseudomonas aeruginosa isolates from Switzerland.docx

Background<p>Increasing reports of multidrug resistance (MDR) in clinical Pseudomonas aeruginosa have led to a necessity for new antimicrobials. Ceftazidime-avibactam (CZA) is indicated for use against MDR P. aeruginosa across a broad range of infection types and particularly those that are ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Baharak Babouee Flury (6828485) (author)
Beste egile batzuk: Anja Bösch (15350398) (author), Valentin Gisler (4997228) (author), Adrian Egli (93521) (author), Salome N. Seiffert (15350401) (author), Oliver Nolte (19650) (author), Jacqueline Findlay (15350404) (author)
Argitaratua: 2025
Gaiak:
Clinical Microbiology
Medical Bacteriology
Medical Infection Agents (incl. Prions)
Medical Virology
Pseudomonas aeruginosa
ceftazidime-avibactam (CZA)
molecular resistance mechanisms
imipenem
whole genome sequencing (WGS)
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak